US Broker Ratings

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 99.55% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering biotechnology company headquartered in Abingdon, United Kingdom, has captured investor attention with an eye-catching potential upside of 99.55%. As a commercial-stage enterprise, Immunocore..

Warby Parker Inc. (WRBY) Stock Analysis: Analyst Ratings and 9.97% Potential Upside Catch Investor Eyes

Warby Parker Inc. (WRBY), an eyeglass behemoth that has disrupted the optics industry, currently finds itself in a compelling position for individual investors to consider. Trading on the healthcare front,..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling a Potential 119% Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a San Diego-based biopharmaceutical company, is drawing significant attention from investors in the biotechnology sector. With a focus on developing treatments for rare kidney and..

Envista Holdings Corporation (NVST) Stock Analysis: Evaluating the 12.89% Potential Upside for Investors

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a mixed picture for potential investors. With a market capitalization of..

BGM Group Ltd. (BGM) Stock Analysis: A Healthcare Player with a Full Year High and Uncertain Valuation

BGM Group Ltd. (BGM), a notable player in the Chinese healthcare sector, has captured investor attention with its impressive stock price performance over the past year. As of the latest..

Neogen Corporation (NEOG) Stock Analysis: A Healthcare Innovator with a 48.51% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on food and animal safety. This US-based company, headquartered in Lansing,..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Promising 142% Upside in the Biotech Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing the attention of investors due to its significant potential upside, as indicated by a compelling average target price of $42.69. With its..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring a 50% Upside Potential in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is catching the attention of investors due to its robust growth prospects and substantial potential upside. With..

Adaptive Biotechnologies (ADPT) Stock Analysis: Promising 24.78% Upside in the Booming Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pivotal player in the biotechnology sector, is making waves in the investment community with its innovative approach to immune medicine. With a market capitalization..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a 163% Potential Upside with Groundbreaking Genetic Medicine Innovations

Beam Therapeutics Inc. (NASDAQ: BEAM), a trailblazer in the biotechnology sector, is capturing investor attention with its ambitious foray into precision genetic medicines. This Cambridge-based company is making strides in..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: A 181% Potential Upside Opportunity

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a pioneering entity in the biotechnology sector, offers a compelling story for investors exploring the healthcare landscape. Specializing in the development of therapeutic antibodies for..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Report: Analyzing a 51% Potential Upside in Dermatological Treatments

In the dynamic and rapidly advancing world of biotechnology, Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is carving out a niche with its innovative approach to dermatological treatments. With a market capitalization..

CG Oncology, Inc. (CGON) Stock Analysis: A 135% Potential Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector may find CG Oncology, Inc. (NASDAQ: CGON) a compelling consideration. With a market capitalization of $1.94 billion, CG Oncology is a..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A Bold Bet on Healthcare Innovation with 33.98% Upside

Investors seeking exposure to the cutting-edge intersection of healthcare and technology may find an intriguing opportunity in PROCEPT BioRobotics Corporation (PRCT). As a pioneering player in the medical devices sector,..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 71% Potential Upside in the Diagnostic & Research Sector

Twist Bioscience Corporation (NASDAQ: TWST) stands at an intriguing juncture for investors, particularly given its potential 71.19% upside as per analyst projections. Operating within the dynamic healthcare sector, Twist Bioscience..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Potential 28.38% Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with its focus on developing, manufacturing, and marketing specialized medical devices and implants for vascular surgery. As an innovative..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: Unpacking a 27.62% Potential Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (GRDN) is capturing investor attention with a promising potential upside of 27.62%, according to recent analyst ratings. Founded in 2003 and headquartered in Atlanta, Georgia, GRDN..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Exploring a 20% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the U.S. healthcare sector, captures investor attention with its significant footprint in the medical care facilities industry. Headquartered in Brentwood,..

Schrödinger, Inc. (SDGR) Investor Outlook: Unveiling a 48.49% Potential Upside Amid Strong Revenue Growth

Investors are turning their attention to Schrödinger, Inc. (NASDAQ: SDGR) as the company showcases a compelling investment narrative within the Healthcare sector, specifically Health Information Services. With a market capitalization..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a Biotech Gem with 154% Upside Potential

For individual investors eyeing the biotechnology sector, Amicus Therapeutics, Inc. (NASDAQ: FOLD) presents a compelling opportunity. Despite the challenges inherent in the biotech industry, Amicus, with its focus on rare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds